Pharmafile Logo
Pharmafocus logo
Advanced Search
pfizer_building_logo1

Pfizer-BioNTech COVID-19 vaccine effective against South Africa variant, companies say

January 28, 2021

Pfizer and BioNTech have said that their COVID-19 vaccine is effective in protecting against the variant of the virus found …

News
china_flag

Harbour BioMed’s Batoclimab granted Breakthrough Therapy designation in China

January 28, 2021
Harbour BioMed

Harbour BioMed (HBM) has announced that China’s Center for Drug Evaluation (CDE) has granted Breakthrough Therapy designation to Batoclimab, a …

News

Pfizer’s rheumatoid arthritis drug fails to meet safety criteria

January 28, 2021
Pfizer

Pfizer has announced that its rheumatoid arthritis (RA) drug XELJANZ (tofacitinib) has failed to meet the co-primary endpoint in its …

News
valneva

Valneva begins production of its COVID-19 vaccine

January 28, 2021
COVID-19, Valneva

Valneva, a specialty vaccine company focused on the prevention of infectious diseases with significant unmet medical needs, has commenced production …

News
celgene_building

NICE recommends Celgene’s REVLIMID for multiple myeloma

January 27, 2021
Research and Development Cancer, Celgene

NICE has issued a Final Appraisal Document (FAD) recommending Celgene’s REVLIMID (lenalidomide) as maintenance treatment after an autologous stem cell …

News

Diurnal and Citrine sign licensing agreement for Alkindi

January 27, 2021
Research and Development Citrine, Diurnal

Diurnal Group has entered into an exclusive licence agreement for its product Alkindi (hydrocortisone granules in capsules for opening) with …

News
european_commission_web

MSD’s cancer therapy KEYTRUDA gets EU approval

January 26, 2021
Manufacturing and Production Cancer, MSD

MSD, known as Merck in the US and Canada, has received approval from the European Commission (EC) for its anti-PD-1 …

News
fdaoutsideweb

FDA approves Aurinia’s oral lupus nephritis therapy

January 26, 2021
Manufacturing and Production Aurinia

The FDA has approved Aurinia Pharmaceuticals’ LUPKYNIS (voclosporin) in combination with a background immunosuppressive therapy regimen to treat adult patients …

News
astrazeneca_building_white

AstraZeneca rejects “incorrect” claims about COVID-19 vaccine efficacy

January 26, 2021
Manufacturing and Production AstraZeneca, COVID-19

AstraZeneca has rejected claims by German media that its COVID-19 vaccine has only 8% efficacy in over-65s. Two German newspapers, …

News
merckincweb

MSD discontinues development of COVID-19 vaccines

January 26, 2021
Manufacturing and Production MSD, Merck

Merck, known as MSD outside of the US and Canada, has announced that the company is discontinuing development of its …

News
abbvie_0

AbbVie’s psoriatic arthritis and ankylosing spondylitis drug gets EU approval

January 26, 2021
Manufacturing and Production AbbVie

The European Commission (EC) has approved AbbVie’s RINVOQTM (upadacitinib 15 mg), an oral, once-daily selective and reversible JAK inhibitor for …

News
drug-trials

How COVID-19 has affected the oncology drugs market

January 25, 2021
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, Cancer

In its disruption to clinical trials and drug supply to patients, the COVID-19 pandemic has impacted the most crucial areas …

Feature

NovAliX and Chemical.AI announce drug discovery collaboration

January 25, 2021
Sales and Marketing Chemical.AI, Novalix

NovAliX, a drug discovery-focused contract research organisation, and Chemical.AI, an artificial intelligence (AI) company, have announced a strategic collaboration in …

News
exelixis

FDA approves Exelixis’ cancer drug Cabometyx

January 25, 2021
Sales and Marketing Cancer, Exelixis

The FDA has approved Exelixis’ Cabometyx (cabozantinib) for patients with advanced renal cell carcinoma (RCC) as a first-line treatment in …

News
brain-1845962_960_720

New study challenges link between stress and migraines

January 25, 2021
Sales and Marketing Curelator, migraine

Digital health platform Curelator has announced new data that shows a lack of association between increased stress and migraine attacks. …

News
genentech_web

Genentech announces positive top-line results for “wet” age-related macular degeneration antibody

January 25, 2021
Sales and Marketing Genentech

Genentech has announced positive top-line results from two identically designed global Phase III studies, TENAYA and LUCERNE, evaluating its investigational …

News
mr058666-web

Merck KGaA’s cancer drug Bavencio gets EU approval

January 25, 2021
Sales and Marketing Merck KGaA

The EC has approved Merck KGaA’s BAVENCIO (avelumab) as monotherapy for the first-line maintenance treatment of adult patients with locally …

News
top_10_image_2_9

Pharmafile.com’s top 10 news stories of the week

January 22, 2021
Medical Communications

A number of Pharmafile.com’s most popular stories this week are surprisingly unrelated to COVID; researchers in Scotland have made a …

News

NICE rejects multiple sclerosis drug Zeposia

January 22, 2021
Medical Communications NICE

NICE has decided not to recommend Bristol Myers Squibb’s Zeposia (ozanimod) for the treatment of relapsing/remitting multiple sclerosis (RRMS). In …

News

Servier and MiNA partner to develop neurological disorder treatments

January 22, 2021
Medical Communications MiNA, Servier

Independent pharmaceutical group Servier and RNA activation-focused MiNA Therapeutics have entered a research partnership to identify and develop small activating …

News
The Gateway to Local Adoption Series

Latest content

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026

Rentschler Biopharma appoints Uwe Buecheler as interim CEO

January 26, 2026

Sandoz’ Ondibta receives European Commission approval for diabetes

January 26, 2026

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026